KORU Medical Systems, Inc. (KRMD)
Data as of , from SEC Form 4 filings.
See up to 3 months of KRMD. The 7-day demo opens the 1M and 3M ranges and puts KRMD on your watchlist.
Start 7-day demoLatest KRMD insider trades
About KORU Medical Systems, Inc. (KRMD)
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
- MAHWAH, NJ
- 73
- 1996
- XNAS
KRMD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 32,000 | $101K |
| Grant or award | 6 | 33,274 | |
| Option exercise | 1 | 75,000 | |
KRMD insider transactions (Form 4)
3661 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Joseph M. Manko Jr. - Director | Grant or award | Common Stock | 5,119 | $0.00 footnote F1 | - | |
| ||||||
| Robert Cascella - Director | Grant or award | Common Stock | 5,119 | $2.93 | $15K | |
| Shahriar Matin - Director | Grant or award | Common Stock | 5,119 | $2.93 | $15K | |
 R. John Fletcher - Director | Grant or award | Common Stock | 7,679 | $2.93 | $22K | |
| Edward Wholihan - Director | Grant or award | Common Stock | 5,119 | $2.93 | $15K | |
| Donna French - Director | Grant or award | Common Stock | 5,119 | $2.93 | $15K | |
| Adam R. Kalbermatten - Officer | Open-market purchase | Common Stock | 32,000 | $3.16 | $101K | |
| Adam R. Kalbermatten - Officer | Option exercise | Common Stock | 75,000 footnote F1 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Tax withholding / forfeiture | Common Stock | 25,483 | $4.26 | $109K | |
| ||||||
| Adam R. Kalbermatten - Officer | Grant or award | Performance Stock Unit | 284,091 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Grant or award | Performance Stock Unit | 286,697 | $0.00 | - | |
| Edward Wholihan - Director | Grant or award | Common Stock | 3,571 | $4.20 | $15K | |
| Shahriar Matin - Director | Grant or award | Common Stock | 3,571 | $4.20 | $15K | |
| Donna French - Director | Grant or award | Common Stock | 3,571 | $4.20 | $15K | |
| R. John Fletcher - Director | Grant or award | Common Stock | 5,357 | $4.20 | $22K | |
| Robert Cascella - Director | Grant or award | Common Stock | 3,571 | $4.20 | $15K | |
| Joseph M. Manko Jr. - Director | Grant or award | Common Stock | 3,571 | $0.00 footnote F1 | - | |
| ||||||
| Adam R. Kalbermatten - Officer | Open-market purchase | Common Stock | 5,000 | $3.96 | $20K | |
| Adam R. Kalbermatten - Officer | Open-market purchase | Common Stick | 7,500 | $3.93 | $29K | |
| Eric Schiller - Officer | Open-market purchase | Common Stock | 5,000 | $3.91 | $20K | |
| Linda M. Tharby - Officer | Open-market purchase | Common Stock | 1,191 | $1,191.00 | $1.42M | |
| Linda M. Tharby - Officer | Option exercise | Common Stock | 13,977 | $0.00 footnote F1 | - | |
| Linda M. Tharby - Officer | Tax withholding / forfeiture | Common Stock | 7,326 | $3.94 | $29K | |
| ||||||
| Christopher Pazdan - Officer | Open-market purchase | Common Stock | 5,000 | $3.88 | $19K | |
| Thomas Edward Adams - Officer | Option exercise | Common Stock | 8,193 | $0.00 footnote F1 | - | |
| Thomas Edward Adams - Officer | Tax withholding / forfeiture | Common Stock | 2,900 | $3.94 | $11K | |
| ||||||
| Joseph M. Manko Jr. - Director | Grant or award | Common Stock | 3,472 | $0.00 | - | |
| Shahriar Matin - Director | Grant or award | Common Stock | 3,472 | $4.32 | $15K | |
| Donna French - Director | Grant or award | Common Stock | 3,472 | $4.32 | $15K | |
| Edward Wholihan - Director | Grant or award | Common Stock | 3,472 | $4.32 | $15K | |
| Robert Cascella - Director | Grant or award | Common Stock | 3,472 | $4.32 | $15K | |
| R. John Fletcher - Director | Grant or award | Common Stock | 5,208 | $4.32 | $22K | |
| Joseph M. Manko Jr. - Director | Grant or award | Common Stock | 3,472 | $0.00 footnote F1 | - | |
| ||||||
| Adam R. Kalbermatten - Officer | Grant or award | Restricted Stock Unit | 45,098 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Grant or award | Performance Stock Unit | 45,098 | $0.00 | - | |
| Adam R. Kalbermatten - Officer | Grant or award | Option to buy Common Stock | 67,779 | $0.00 | - | |
Recent KRMD Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| KALBERMATTEN ADAM R | Officer | 25,483 | $109K | View on EDGAR | |
| - | - | - | - |
KRMD insider trading FAQ
What is the latest insider trade for KRMD?
KORU Medical Systems, Inc. (KRMD) had 8 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for KRMD runs to 61 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KRMD stock?
1 insider purchase of KRMD was filed in the last 90 days, totaling $101K.
How many insiders are selling KRMD stock?
No insider sales of KRMD were filed in the last 90 days.
Where can I see KRMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KRMD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Joseph M. Manko Jr. view on EDGAR
- - Robert Cascella view on EDGAR
- - Shahriar Matin view on EDGAR
- - R. John Fletcher view on EDGAR
- - Edward Wholihan view on EDGAR
- - Donna French view on EDGAR
- - Adam R. Kalbermatten view on EDGAR
- - Adam R. Kalbermatten view on EDGAR
- - Adam R. Kalbermatten view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where KRMD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KRMD with a 7-day demo
- KRMD on your watchlist
- Every KRMD Form 4 filing on record
- Up to 3 months of KRMD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
